Mereo Biopharma Group Plc(MREO)
盘后0.42090.00-0.71%19:35 EST
0.4239-0.0081-1.87%
行情数据延迟15分钟
- 最新
- 推荐
暂无内容公司概况
公司名称Mereo Biopharma Group Plc所属市场NASDAQ成立日期- -员工人数- -办公地址- -邮政编码- -联系电话- -联系传真- -公司概况Mereo BioPharma Group plc于2015年3月10日根据英格兰和威尔士法律注册成立。该公司是一家专注于罕见病创新疗法开发的生物制药公司。它已经建立了一个后期临床候选产品组合，包括用于成骨不全症的setrusumab和用于α-1抗胰蛋白酶缺乏相关肺部疾病的alvelestat。该公司的战略涉及有选择地获取和开发通过先前研发取得进展的罕见病候选产品。- 02-17Form 8-K - Current report重要事件披露Form 8-K - Current report
- 02-02Form S-8 - Securities to be offered to employees in employee benefit plans员工持股计划Form S-8 - Securities to be offered to employees in employee benefit plans
- 01-12Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-12-29Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-11-10Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-11-10Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-08-12Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-08-12Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-07-10Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-05-14Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-05-13Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-05-13Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-03-26Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]年度报告Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
- 2025-03-26Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-01-23Form S-8 - Securities to be offered to employees in employee benefit plans员工持股计划Form S-8 - Securities to be offered to employees in employee benefit plans
- 分时
- 5日
- 日
- 周
- 月
数据加载中...
最高
0.4543
今开
0.4356
量比
0.72
最低
0.4136
昨收
0.4320
换手率
2.44%